215 related articles for article (PubMed ID: 26619158)
21. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
Zheng Y; Zhang H; Hu Y; Bai L; Xue J
Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
[TBL] [Abstract][Full Text] [Related]
22. Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo.
Hu X; Ji Y; Wang M; Miao F; Ma H; Shen H; Jia N
J Biomed Nanotechnol; 2013 Jun; 9(6):976-84. PubMed ID: 23858961
[TBL] [Abstract][Full Text] [Related]
23. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
24. Polyaspartic acid coated manganese oxide nanoparticles for efficient liver MRI.
Xing R; Zhang F; Xie J; Aronova M; Zhang G; Guo N; Huang X; Sun X; Liu G; Bryant LH; Bhirde A; Liang A; Hou Y; Leapman RD; Sun S; Chen X
Nanoscale; 2011 Dec; 3(12):4943-5. PubMed ID: 22064945
[TBL] [Abstract][Full Text] [Related]
25. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
[TBL] [Abstract][Full Text] [Related]
26. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
Huang CC; Khu NH; Yeh CS
Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
[TBL] [Abstract][Full Text] [Related]
27. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
28. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
[TBL] [Abstract][Full Text] [Related]
29. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
30. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Field-Optimized Paramagnetic Nanoprobe for
Huo L; Zeng J; Wang Z; Sun X; Guo Y; Cao Z; Zhu S; Tan M; Li M; Chen X; Zhao Z
ACS Nano; 2024 May; 18(19):12453-12467. PubMed ID: 38686995
[TBL] [Abstract][Full Text] [Related]
32. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
[TBL] [Abstract][Full Text] [Related]
33. Mn(II) compounds as an alternative to Gd-based MRI probes.
Botta M; Carniato F; Esteban-Gómez D; Platas-Iglesias C; Tei L
Future Med Chem; 2019 Jun; 11(12):1461-1483. PubMed ID: 31298575
[TBL] [Abstract][Full Text] [Related]
34. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
Kohler N; Sun C; Fichtenholtz A; Gunn J; Fang C; Zhang M
Small; 2006 Jun; 2(6):785-92. PubMed ID: 17193123
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics.
Ren Q; Yang K; Zou R; Wan Z; Shen Z; Wu G; Zhou Z; Ni Q; Fan W; Hu J; Liu Y
Nanoscale; 2019 Dec; 11(47):23021-23026. PubMed ID: 31774090
[TBL] [Abstract][Full Text] [Related]
37. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of L-DOPA coated iron oxide nanoparticles in intraperitoneal delivery setting - preliminary preclinical study.
Comănescu MV; Mocanu MA; Anghelache L; Marinescu B; Dumitrache F; Bădoi AD; Manda G
Rom J Morphol Embryol; 2015; 56(2 Suppl):691-6. PubMed ID: 26429160
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging of human embryonic stem cells.
Chung J; Yamada M; Yang PC
Curr Protoc Stem Cell Biol; 2009 Aug; Chapter 5():Unit 5A.3. PubMed ID: 19653198
[TBL] [Abstract][Full Text] [Related]
40. Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their
Miao Y; Xie Q; Zhang H; Cai J; Liu X; Jiao J; Hu S; Ghosal A; Yang Y; Fan H
Theranostics; 2019; 9(6):1764-1776. PubMed ID: 31037137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
